| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 72.00K | -1.51M | -4.84M | -1.23M | -3.06M |
| EBITDA | -25.54M | -19.16M | -48.70M | 68.49M | -662.26M |
| Net Income | -22.23M | -19.17M | -27.11M | 45.15M | -526.23M |
Balance Sheet | |||||
| Total Assets | 2.66B | 2.68B | 2.83B | 3.44B | 3.31B |
| Cash, Cash Equivalents and Short-Term Investments | 65.85M | 108.87M | 136.71M | 163.17M | 163.14M |
| Total Debt | 369.00K | 1.79M | 282.00K | 1.47M | 282.00K |
| Total Liabilities | 18.38M | 27.28M | 21.47M | 19.68M | 22.63M |
| Stockholders Equity | 2.12B | 2.13B | 2.25B | 2.74B | 2.64B |
Cash Flow | |||||
| Free Cash Flow | -43.91M | -28.68M | -26.93M | -28.93M | -37.39M |
| Operating Cash Flow | -36.01M | -18.08M | -19.57M | -20.99M | -31.32M |
| Investing Cash Flow | -5.55M | -10.41M | -5.55M | 22.79M | -4.20M |
| Financing Cash Flow | -1.46M | -1.25M | -1.23M | -1.18M | -1.37M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$16.37B | 14.89 | 23.61% | 0.44% | 6.76% | 239.14% | |
72 Outperform | HK$97.00B | 12.48 | 25.32% | 0.54% | ― | ― | |
66 Neutral | HK$36.89B | 13.75 | 33.81% | 1.40% | 70.92% | 249.45% | |
64 Neutral | HK$115.06B | 27.53 | 11.01% | 0.16% | 44.37% | 125.87% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
54 Neutral | HK$4.40B | 21.71 | 19.93% | ― | 59.18% | 28.00% | |
40 Underperform | HK$834.97M | -31.17 | -1.02% | ― | ― | -25.51% |